Hisataka Shoji

Summary

Affiliation: Toray Industries
Country: Japan

Publications

  1. ncbi Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)
    Hisataka Shoji
    Division of Planning and Science, Department of Blood Purification Medical Devices, Toray Medical Co, Tokyo, Japan
    Ther Apher Dial 7:108-14. 2003
  2. ncbi Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Tokyo, Japan
    Blood Purif 23:417-20. 2005
  3. ncbi Effect over time of endotoxin adsorption therapy in sepsis
    Takuya Ueno
    Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan
    Ther Apher Dial 9:128-36. 2005
  4. ncbi Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Blood Purif 22:256-60. 2004
  5. ncbi Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:41-4. 2002
  6. ncbi Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience
    Takashi Sato
    Kidney Center, Koga Hospital, Kurume, Fukuoka Japan
    Ther Apher Dial 7:252-8. 2003
  7. ncbi Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    Nephron Clin Pract 94:c33-9. 2003
  8. ncbi Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:244-8. 2002
  9. ncbi Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Am J Med Sci 334:244-7. 2007
  10. ncbi Removal of endotoxin in blood by polymyxin B immobilized polystyrene-derivative fiber
    Kazuo Teramoto
    Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Japan
    Ther Apher 6:103-8. 2002

Collaborators

  • Takashi Sato
  • Takuya Ueno
  • Tsukasa Nakamura
  • Hikaru Koide
  • Yasuhiro Kawagoe
  • Yoshihiko Ueda
  • Chifuyu Ushiyama
  • Tsukasa Suzuki
  • Noriaki Shimada
  • Yoshimasa Suzuki
  • Kazuo Teramoto
  • Noriyoshi Kobayashi
  • Isao Ebihara
  • Takaharu Matsuda
  • Naoaki Tamura
  • Shiwori Osada
  • Teruo Inoue
  • Masanori Hara
  • Tetsunosuke Kunitomo
  • Kazuyoshi Hanazawa
  • Masashi Kodama
  • Yoshiaki Nakamoto
  • Toru Tani

Detail Information

Publications10

  1. ncbi Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)
    Hisataka Shoji
    Division of Planning and Science, Department of Blood Purification Medical Devices, Toray Medical Co, Tokyo, Japan
    Ther Apher Dial 7:108-14. 2003
    ..Further studies are now ongoing to establish Toraymyxin treatment as one of the options to treat sepsis and septic shock patients and to clarify the mechanisms involved in this therapy...
  2. ncbi Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Tokyo, Japan
    Blood Purif 23:417-20. 2005
    ..CONCLUSIONS: IL-18 may be associated with the severity of septic shock, and PMX-F treatment is effective in reducing the IL-18 level in patients with septic shock...
  3. ncbi Effect over time of endotoxin adsorption therapy in sepsis
    Takuya Ueno
    Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan
    Ther Apher Dial 9:128-36. 2005
    ....
  4. ncbi Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Blood Purif 22:256-60. 2004
    ..01, TIMP-1 220.6 +/- 30.5 ng/ml, p < 0.01). CONCLUSION: These data suggest that MMP-9 and TIMP-1 may play a role in the pathogenesis of ARDS and that PMX-F treatment ameliorated increased MMP-9 and TIMP-1 levels in ARDS patients...
  5. ncbi Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:41-4. 2002
    ..PMX-F is effective in reducing myocardial damage, in part, due to reducing plasma endotoxin levels...
  6. ncbi Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience
    Takashi Sato
    Kidney Center, Koga Hospital, Kurume, Fukuoka Japan
    Ther Apher Dial 7:252-8. 2003
    ..Further studies are needed to clarify the mechanisms of PMX treatment and to strengthen the scientific basis of this treatment...
  7. ncbi Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    Nephron Clin Pract 94:c33-9. 2003
    ..CONCLUSION: PMX-F treatment may be effective in reducing urinary protein and urinary podocyte excretion in septic patients with MRSA-associated glomerulonephritis...
  8. ncbi Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:244-8. 2002
    ..Neither MACR nor plasma endotoxin levels were affected by conventional treatment, however. In summary, trauma patients with sepsis appear to show increased MACR, and PMX-F therapy may be effective for attenuating the increase in MACR...
  9. ncbi Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Am J Med Sci 334:244-7. 2007
    ..The aim of the present study was to determine whether PMX-F treatment with the PMX-05R column is effective in elderly patients with septic shock...
  10. ncbi Removal of endotoxin in blood by polymyxin B immobilized polystyrene-derivative fiber
    Kazuo Teramoto
    Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Japan
    Ther Apher 6:103-8. 2002
    ..The adsorption of endotoxin was confirmed by desorption of LPS from PMX-F as well. PMX-F adsorbed serum amyloid protein A besides LPS, but neither C-reactive protein nor low-density lipoprotein. The adsorbing property of heparin was low...